Management cited that all customer migrations to the latest Calix platform are complete, removing related dual cloud costs ...

Loan Originations -- $42.1 million in loans held for investment were originated, representing a 42% increase compared to the ...

Add-on Revenue -- Increased 67% year over year in Q4, supported by new features such as back-in-stock notifications and ...

In Q1 2026, Ekinops' consolidated revenue amounted to 27.6 m€, up +8% vs. Q4 2025 (25.6 m€), marking a second consecutive quarter of improved activity. Olfeo, the French provider of SSE (Secure ...

A sequential, multiple assignment, randomized trial (SMART) found that people with chronic low back pain experienced slight ...

Developed by Professor Sanjay Mehrotra, the Sliding Scale AdaptiVe Expedited (SAVE) algorithm could improve organ allocation ...

Learn how early coordination across functions, phases and partners can reduce risk and accelerate drug development.

Q4 Operating Loss -- $730,000, compared to a $513,000 loss last year, and a $1.2 million loss in Q3. Q4 Net Loss Per Share -- ...

Beta Bionics (NASDAQ:BBNX) reported first-quarter 2026 net sales of $27.6 million, up 57% year-over-year, as management cited growth in new patient starts, a rising base of recurring pharmacy users, ...

Tesla reports Q1 2026 earnings tomorrow with Wall Street expecting $21.9B revenue and $0.36 EPS. But missed deliveries, ...

Q1 2026 earnings call highlights: record $280M revenue, raised 2026 growth to 15–20%, margin risks from memory surcharges—read now.

Eliminated substantially all of the Company’s debt, ended the year with $6.8 million in Cash and $8.2 million of Stockholders’ Equity.Fourth ...